Canadian obesity guideline emphasizes individualized medication decisions
The update considers health complications, central body fat and personal preferences when discussing obesity medication, drawing on an evidence review and stakeholder feedback.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This guideline recommends tailoring obesity medication decisions to a person's health needs, values and preferences, alongside health behavior changes. It supports long-term medication use for sustained weight management and makes recommendations for specific clinical subgroups. These are guideline recommendations; the abstract does not provide trial-level estimates for individual medications, benefits or harms.
The abstract summarizes recommendations without naming the recommended drugs for each subgroup or presenting their effect sizes and safety results. Abstract-only access cannot support comparisons between medications or an individualized prescribing decision.
How the guidance was developed
The authors reviewed weight-management medication research and conducted targeted searches on complications associated with excess body fat. Primary care clinicians, obesity specialists and people with lived experience of obesity contributed feedback on the recommendations.
Why the subgroup details matter
The guideline distinguishes people with particular conditions, including cardiovascular disease, sleep apnea and osteoarthritis. Its recommendations for these groups should be read in that clinical context, rather than treated as evidence that every medication benefits everyone.
The original publication
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update.
Pedersen SD, Manjoo P, Dash S et al.
CMAJ · 2025
- PubMed ID
- 40789597
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.